Epicentrx Is An Innovation Driven Clinical Stagedrug And Devicecompany That Puts Theemphasis Oneaseeaseof Treatmenteaseof Sideeffectsand Easeof Symptoms During Thetreatment Of A Rangeof Diseases Including Lung Cancerand Head And Neck Cancerand Different Inflammatory Disorders For Which Thecompany Has Received Several Grants And Orphan Designations Thelead Deviceis Called Theeloop And Thelead Therapies Arethedirect Nlrp Inhibitornibrozetonerrx 001 And Thetgf I Trap Enhanced Oncolytic Adenovirusadapt 001In Phase And Phase2 Clinical Trialsrespectively
